Targeted approaches to the treatment of pulmonary hypertension

Therapy for Pulmonary Arterial Hypertension: The More, the Merrier?

(2013) Darren B. Taichman   ANNALS OF INTERNAL MEDICINE

Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension

(2013) Gérald Simonneau   ANNALS OF INTERNAL MEDICINE

Safety and Efficacy of Bosentan in Combination With Sildenafil in PAH Patients Who Experience Inadequate Clinical Response to Monotherapy: The COMPASS-3 Study

(2011) Raymond L. Benza et al.   CHEST

Hepatic Transaminase Abnormalities in Pulmonary Arterial Hypertension: A Report From the REVEAL Registry

(2011) David Badesch et al.   CHEST

The Effect of Diluent pH on Bloodstream Infection Rates in Patients Receiving IV Treprostinil for Pulmonary Arterial Hypertension

(2011) Jonathan D. Rich et al.   CHEST

Pregnancy and Pulmonary Hypertension

(2011) C. Randall Lane et al.   CLINICS IN CHEST MEDICINE

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension

(2011) Raymond L. Benza et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Combination therapy in pulmonary arterial hypertension: do we have the right strategy?

(2011) Bhashkar Mukherjee et al.   Expert Review of Respiratory Medicine

Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach

(2010) DG Kiely et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Safety and Efficacy of Ambrisentan for the Treatment of Portopulmonary Hypertension

(2010) Rodrigo Cartin-Ceba et al.   CHEST

The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States

(2010) Adaani E. Frost et al.   CHEST

Predicting Survival in Pulmonary Arterial Hypertension

(2010) Raymond L. Benza et al.   CIRCULATION

Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension

(2010) D. Montani et al.   EUROPEAN HEART JOURNAL

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

(2010) M. Humbert et al.   EUROPEAN RESPIRATORY JOURNAL

Emerging drugs for pulmonary hypertension

(2010) Reda E Girgis   EXPERT OPINION ON EMERGING DRUGS

Stability and antimicrobial effectiveness of treprostinil sodium in Sterile Diluent for Flolan

(2010) D. Zaccardelli et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey

(2010) Martha S. Kingman et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations

(2010) Michael A. Mathier et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension

(2010) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Arterial Hypertension

(2009) David B. Badesch et al.   CHEST

Tadalafil Therapy for Pulmonary Arterial Hypertension

(2009) Nazzareno Galiè et al.   CIRCULATION

Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?

(2009) E. Bedard et al.   EUROPEAN HEART JOURNAL

Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation

(2009) T. Thenappan et al.   EUROPEAN RESPIRATORY JOURNAL

Closed-Hub Systems with Protected Connections and the Reduction of Risk of Catheter-Related Bloodstream Infection in Pediatric Patients Receiving Intravenous Prostanoid Therapy for Pulmonary Hypertension

(2009) D. Dunbar Ivy et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension

(2009) Ronald J. Oudiz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

(2009) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension

(2009) Robyn J. Barst et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cellular and Molecular Basis of Pulmonary Arterial Hypertension

(2009) Nicholas W. Morrell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inflammation, Growth Factors, and Pulmonary Vascular Remodeling

(2009) Paul M. Hassoun et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Clinical Classification of Pulmonary Hypertension

(2009) Gérald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Nazzareno Galiè et al.   CIRCULATION

Prostacyclin therapies for the treatment of pulmonary arterial hypertension

(2008) M. Gomberg-Maitland et al.   EUROPEAN RESPIRATORY JOURNAL

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

(2008) N Galiè et al.   LANCET